The author(s) report no funding was provided for this work.
The limited availability of biological samples from patients testing positive for SARS-CoV-2 for future research was quickly identified at the onset of the COVID-19 pandemic. In response to this need, a COVID-19 biobank was initiated by the University of Louisville Division of Infectious Diseases, Center of Excellence for Research in Infectious Diseases (CERID). The COVID-19 biobank contains waste samples obtained from patients hospitalized with COVID-19 in any of the nine Louisville, Kentucky, area hospitals during the timeframe of April 13 to September 20, 2020. The COVID-19 biobank stores approximately 1,623 waste samples with 2,127 aliquots for distribution. All samples are linked to clinical data. The methods described in this paper are intended for use as a guide for other research institutions interested in developing a COVID-19 biobank.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Balcom, Dawn; Wolf, Leslie A; Marimuthu, Subathra; Johnson, William; Malik, Danial; Dhakal, Chet; Nathala, Pavani; Abbas, Mohammed; Hardeep Singh, Sahaj; Haddad, Basel; Elbeblawy, Rafik; Deepti, Fnu; Ali, Ahmed; Exposito Gonzalez, Evelyn; and Carrico, Ruth
"Implementation of the University of Louisville COVID-19 Biorepository: Experiences from the Center of Excellence in Infectious Diseases (CERID),"
The University of Louisville Journal of Respiratory Infections: Vol. 4
, Article 71.
Available at: https://ir.library.louisville.edu/jri/vol4/iss1/71